Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis.
Mengtao LiZhi-Cheng JingYang LiYong HuoZaixin YuGangcheng ZhangPing ZhuJinming LiuQiushang JiBingxiang WuJinhua ZhongPingping WangWenjing ZhuXiao-Feng ZengPublished in: BMC cardiovascular disorders (2020)
ClinicalTrial.gov Identifier, https://clinicaltrials.gov/, NCT01808313 Registration date (first time): February 28, 2013.